Application of serum type III procollagen peptide level in the diagnosis of lung fibrosis developed during bleomycin treatment in cancer patients

I. Okazaki, K. Miura, S. Ohya, M. Murakami, N. Nagata, K. Maruyama, T. Kobayashi, F. Okuno, S. Oda, H. Ito

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)2104-2111
Number of pages8
JournalJournal of Japan Society for Cancer Therapy
Volume20
Issue number9
Publication statusPublished - 1985 Dec 1

ASJC Scopus subject areas

  • Cancer Research

Cite this

Okazaki, I., Miura, K., Ohya, S., Murakami, M., Nagata, N., Maruyama, K., Kobayashi, T., Okuno, F., Oda, S., & Ito, H. (1985). Application of serum type III procollagen peptide level in the diagnosis of lung fibrosis developed during bleomycin treatment in cancer patients. Journal of Japan Society for Cancer Therapy, 20(9), 2104-2111.